Your account is not claimed yet. You can sign up with ORCID to claim your account.

Mayur Garg

ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 26

Top Venues

Alimentary pharmacology & therapeutics

Internal medicine journal

Gut

JGH open : an open access journal of gastroenterology and hepatology

Melbourne Health

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Melbourne Health

Australia

Gastroenterologist :: Gastro

Publications

Sarah E Lucas, Mayur Garg
Intravenous iron: an update. Internal medicine journal (2023)
Ayushi Chauhan, Mayur Garg
Editorial: faecal microbiota transplantation for recurrent C. difficile infections-getting the support that is needed. Alimentary pharmacology & therapeutics 57 (5) (2023)
Robert Gilmore, Sheng W Lo, Rachael Cheong, Syeda Tahiya Karim, Deborah Farrah, Soleiman Kashkooli, Jonathan P Segal, Mayur Garg
Factors associated with long-term healthcare expense and steroid exposure in patients admitted with acute severe ulcerative colitis. JGH open : an open access journal of gastroenterology and hepatology 7 (7) (2023)
Sarah E Lucas, Ayushi Chauhan, Mayur Garg
Letter: delays to diagnosis of IBD-Challenges requiring a systematic approach. Alimentary pharmacology & therapeutics 57 (12) (2023)
Ayushi Chauhan, Sarah Lucas, Mayur Garg
Hypophosphataemia following ferric carboxymaltose and ferric derisomaltose: case closed, but questions remain. Gut (2023)
Melissa Chew, Julien Dion Schulberg, Prithi Bhathal, Tom R Sutherland, Mayur Garg
An unusual cause of colonic ulceration. Gut (2022)
Sheng Wei Lo, Mayur Garg, Jonathan P Segal
Letter: normalising the ileoanal pouch-more than a one-step technique. Alimentary pharmacology & therapeutics 56 (1) (2022)
Aysha H Al-Ani, null null, Mayur Garg
Development of inflammatory bowel disease patient education and medical information sheets: serving an unmet need. Internal medicine journal 52 (7) (2022)
Andrew H Tsoi, Anand Murugasu, Mayur Garg
Letter: assessment of histological disease activity in Crohn's disease clinical trials-a step in the right direction, but further optimisation needed. Alimentary pharmacology & therapeutics 54 (4) (2021)
Lynna Chen, Simon Glance, Mayur Garg
Letter: response of eosinophilic oesophagitis to proton pump inhibitor therapy-the importance of biopsies at index endoscopy. Alimentary pharmacology & therapeutics 54 (4) (2021)
Daniel Saitta, Mayur Garg
Letter: missed opportunities for the diagnosis of colorectal cancer in patients with inflammatory bowel disease-still significant room for improvement. Alimentary pharmacology & therapeutics 54 (5) (2021)
Gurpreet Singh, Ralley Prentice, David Langsford, Britt Christensen, Mayur Garg
Altered bowel habit and rectal bleeding in pregnancy: the importance of recognising undiagnosed inflammatory bowel disease. Internal medicine journal 51 (3) (2021)
Ayushi Chauhan, Ross Apostolov, Daniel R Van Langenberg, Mayur Garg
Faecal microbiota transplantation for recurrent Clostridioides difficile infection: an Australian experience - effective, safe, yet room for improvement. Internal medicine journal 51 (1) (2021)
Mayur Garg, Sheital Chand, Petrus Weenink, Karen Yunqiu Wu, Richard K Y Cheng
Letter: assessing iron deficiency in patients with IBD-a step in the right direction, but uncertainty remains. Alimentary pharmacology & therapeutics 52 (2) (2020)
Wendy Fang, Rachel Kenny, Qurat-Ul-Ain Rizvi, Lawrence P McMahon, Mayur Garg
Hypophosphataemia after ferric carboxymaltose is unrelated to symptoms, intestinal inflammation or vitamin D status. BMC gastroenterology 20 (1) (2020)
Mayur Garg, Simon G Royce, John S Lubel
Letter: intestinal inflammation, COVID-19 and gastrointestinal ACE2-exploring RAS inhibitors. Alimentary pharmacology & therapeutics 52 (3) (2020)
Aysha H Al-Ani, Ralley E Prentice, Clarissa A Rentsch, Doug Johnson, Zaid S Ardalan, Neel M Heerasing, Mayur Garg, Sian Campbell, Joe Sasadeusz, Finlay A Macrae, William K K Wu, David T Rubin, Britt Christensen
Review article: prevention, diagnosis and management of COVID-19 in the IBD patient. Alimentary pharmacology & therapeutics 52 (1) (2020)
Hannah Mitchell, Mayur Garg
Editorial: a non-dietary treatment for coeliac disease-two steps forward, one step back? Alimentary pharmacology & therapeutics 50 (8) (2020)
Ralley E Prentice, Douglas Tjandra, Mayur Garg, John S Lubel, Spiros Fourlanos, Doug Johnson, Aysha Al-Ani, Britt Christensen
Letter: ACE2, IBD and COVID-19-why IBD patients may be at reduced risk of COVID-19. Alimentary pharmacology & therapeutics 52 (8) (2020)
Mayur Garg, Aysha Al-Ani, Hannah Mitchell, Philip Hendy, Britt Christensen
Editorial: low population mortality from COVID-19 in countries south of latitude 35 degrees North-supports vitamin D as a factor determining severity. Authors' reply. Alimentary pharmacology & therapeutics 51 (12) (2020)
Hannah Mitchell, Judi Porter, Peter R Gibson, Jacqueline Barrett, Mayur Garg
Letters: low FODMAP diet-directions for future research and the low FODMAP diet is not the only diet for IBS-authors' reply. Alimentary pharmacology & therapeutics 49 (8) (2020)
Mayur Garg, Simon G Royce, Chris Tikellis, Claire Shallue, Pavel Sluka, Hady Wardan, Patrick Hosking, Shaun Monagle, Merlin Thomas, John S Lubel, Peter R Gibson
The intestinal vitamin D receptor in inflammatory bowel disease: inverse correlation with inflammation but no relationship with circulating vitamin D status. Therapeutic advances in gastroenterology 12 (2019)
Hannah Mitchell, Judi Porter, Peter R Gibson, Jacqueline Barrett, Mayur Garg
Review article: implementation of a diet low in FODMAPs for patients with irritable bowel syndrome-directions for future research. Alimentary pharmacology & therapeutics 49 (2) (2019)
Mayur Garg, Simon G Royce, Chris Tikellis, Claire Shallue, Duygu Batu, Elena Velkoska, Louise M Burrell, Sheila K Patel, Lauren Beswick, Anvesh Jackson, Kaushali Britto, Matthew Lukies, Pavel Sluka, Hady Wardan, Yumiko Hirokawa, Chin Wee Tan, Maree Faux, Antony W Burgess, Patrick Hosking, Shaun Monagle, Merlin Thomas, Peter R Gibson, John Lubel
Imbalance of the renin-angiotensin system may contribute to inflammation and fibrosis in IBD: a novel therapeutic target? Gut 69 (5) (2019)
Wendy C Fang, Lawrence P McMahon, Stephen Bloom, Mayur Garg
Symptomatic severe hypophosphatemia after intravenous ferric carboxymaltose. JGH open : an open access journal of gastroenterology and hepatology 3 (5) (2019)
Emma K Flanagan, Peter R Gibson, Jacob Begun, Simon Ghaly, Mayur Garg, Jane M Andrews, Ourania Rosella, Gennaro Rosella, Sally J Bell
Letter: vedolizumab drug concentrations in neonates following intrauterine exposure. Alimentary pharmacology & therapeutics 48 (11-12) (2019)

Mayur Garg.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Mayur Garg